Recon: Pfizer wins RSV vaccine patent fight; Baxter uncertain when hurricane-hit plant will reopen – Regulatory Focus

Recon: Pfizer wins RSV vaccine patent fight; Baxter uncertain when hurricane-hit plant will reopen  Regulatory Focus